期刊文献+

全甲状腺切除加功能性颈淋巴结清扫治疗甲状腺乳头状癌172例 被引量:20

Total thyroidectomy plus functional neck lymph node dissection for the treatment of papillary thyroid carcinoma
原文传递
导出
摘要 目的 探讨甲状腺乳头状癌颈淋巴结转移模式以及全甲状腺切除+功能性颈淋巴结清扫术在甲状腺乳头状癌治疗中的作用.方法 回顾性分析一期全甲状腺切除+功能性颈淋巴结清扫术治疗的172例甲状腺乳头状癌患者的临床和病理资料.结果 172例患者的219侧功能性颈淋巴结清扫结果提示颈淋巴结转移率依次为Ⅵ区(96.3%)、Ⅳ区(78.5%)、Ⅲ区(62.1%).肿瘤浸润甲状腺被膜者颈淋巴结转移率明显增高(P<0.05).124例术后1 d血清甲状旁腺素(15.87±8.03)pg/ml较术前(37.68±15.0)pg/ml显著降低(P<0.01).患者5年、10年和15年的生存率分别为(98.83±0.82)%、(98.23±1.02)%和(96.42±1.43)%.结论 术中快速冰冻切片是确定Ⅵ区淋巴结病理状态的可靠方法.准确掌握全甲状腺切除+功能性颈淋巴结清扫术的适应证,术后患者可获得长期生存. Objective To explore the pattern of cervical nodal metastasis and the clinical significance of total thyroidectomy plus functional neck lymphadenectomy in papillary thyroid carcinoma patients. Methods Clinical and pathological data of 172 patients with papillary thyroid cancer who underwent total thyroidectomy plus functional neck lymph node dissection at Jinan Military General Hospital were retrospectively reviewed, including patient demographics, extent of surgery, parathyroid hormone level,recurrence, tumor pathology, such as tumor size, multifocality, capsular invasion, vascular invasion,extrathyroidal extension, and lymph node status. Results Of the 172 functional neck dissection patients (47 ambilateral), the incidence of lymphonodus metastasis in regions Ⅵ, Ⅳ and Ⅲ was 96. 3% ,78. 5%and 62.1% respectively. Rate of nodal metastasis was higher in patients with extracapsular invasion than in patients with no invasion ( P 〈 0. 05 ). Serum parathyroid hormone levels significantly decreased immediately postoperatively in total thyroidectomy plus functional neck dissection and remained low for several weeks thereafter ( P 〈 0. 01 ). The 5-, 10- and 15-year survival rate was ( 98. 83 ± 0. 82) %, (98. 23 ± 1.02 ) % and (96. 42 ± 1.43 )%, respectively. Conclusions Therapeutic neck lymph node dissection for papillary thyroid cancer is recommended for cervical nodal metastasis patients. Total thyroidectomy plus functional neck dissection is important in the treatment of papillary thyroid cancer.
出处 《中华普通外科杂志》 CSCD 北大核心 2010年第8期611-615,共5页 Chinese Journal of General Surgery
关键词 甲状腺肿瘤 甲状腺切除术 颈淋巴结清扫术 甲状旁腺素 Thyroid neoplasms Thyroidectomy Neck dissection Parathyroid hormone
  • 相关文献

参考文献10

  • 1Zaydfudim V,Feurer ID,Griffin MR,et al.The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.Surgery,2008,144:1070-1078.
  • 2Kim TY,Hong SJ,Kim JM,et al.Prognostic parameters for recurrence of papillary thyroid microcarcinoma.BMC Cancer,2008,14:296-307.
  • 3Davidson HC,Park BJ,Johnson JT.Papillary thyroid cancer:controversies in the management of neck metastasis.Laryngoscope,2008,118:2161-2165.
  • 4Pitt SC,Sippel RS,Chen H.Contralateral papillary thyroid cancer:does size matter? Am J Surg,2009,197:342-347.
  • 5Chagas JF,Aquino JL,Pascoal MB,et al.Multicentricity in the thyroid differentiated carcinoma.Braz J Otorhinolaryngol,2009,75:97-100.
  • 6Ito Y,Miyauchi A.Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.Endocr J,2009,56:177-192.
  • 7Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16:109-142.
  • 8Choi SJ,Kim TY,Lee JC,et al.Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma? Clin Exp Otorhinolaryngol,2008,1:41-45.
  • 9Díez Alonso M,Sánchez López JD,Sánchez-Seco Pe(m)a MI,et al.Serum PTH levels as a predictive factor of hypocalcaemia after total thyroidectomy.Cir Esp,2009,85:96-102.
  • 10Roh JL,Park JY,Park CI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients:pattern of nodal metastasis,morbidity,recurrence,and postoperative levels of serum parathyroid hormone.Ann Surg,2007,245:604-610.

同被引文献228

  • 1谢小军,陈余钿,嵇庆海.甲状腺腺叶切除术后血清甲状腺激素水平的变化[J].中华普通外科杂志,2005,20(3):162-163. 被引量:12
  • 2于建军,周东华.甲状腺微小癌1089例手术病例分析[J].国际医药卫生导报,2006,12(17):37-38. 被引量:9
  • 3石岚,黄韬.甲状腺乳头状癌淋巴结转移规律的研究[J].中华普通外科杂志,2007,22(7):524-526. 被引量:53
  • 4Hughes D T, Haymart M R, Miller B S, et al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 yearsE J]. Thyroid, 2011, 21 ( 3 ) :231-236.
  • 5Cramer J D, Fu P, Harth K C, et al. Analysis of the ris- ing incidence of thyroid cancer using the Surveillance, Ep- idemiology and End Results national cancer data registry ~J]. Surgery, 2010, 148(6) :1147-1153.
  • 6Chen A Y, Jemal A, Ward E M. Increasing incidence of differentiated thyroid cancer in the United States, 1988- 2005 [J].Cancer, 2009, 115 (16) :3801-3807.
  • 7Clark O H. Thyroid cancer and lymph node metastases[J]. J Surg Oncol, 2011, 103(6) :615-618.
  • 8Leenhardt L, Grosclaude P. Epidemiology of thyroid car- cinoma over the world C J I. Ann Endocrinol (Paris), 2011, 72(2) :136-148.
  • 9LiVolsi V A. Papillary thyroid carcinoma: an update[J]. Mod Pathol, 2011, 24 (2) :S1-9.
  • 10Brassard M, Borget I, Edet-Sanson A, et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients[J]. J Clin En- docrinol Metab, 2011, 96(5) :1352-1359.

引证文献20

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部